EyeCool Therapeutics12 hours agoEyeCool Therapeutics to Present at BTIG’s 5th Annual Ophthalmology Day
EyeCool TherapeuticsSeptember 2, 2025EyeCool Therapeutics Appoints Dr. Vance Thompson to Board of Directors
EyeCool TherapeuticsAugust 7, 2025EyeCool Therapeutics Announces Promising Results from Double-Masked Randomized Controlled Trial in Chronic Ocular Surface Pain (COSP)
EyeCool TherapeuticsMay 7, 2025EyeCool Therapeutics Announces Promising Results from Double-Masked Randomized Controlled Trial in Chronic Ocular Surface Pain (COSP)
